ArticleFrontiers in oncology2022

Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients.

Gaofeng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.